Clinical Trial Update: Bleomycin in Treating Patients With Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Bleomycin for Non-Hodgkin lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Bleomycin (bleomycin)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Lymphoma | Phase 2 | Status: COMPLETED